Clinical Trial

Risk Stratification of MACE in Heart Failure Patients Who Undergoing CABG

Study acronym: PROFILE-HF
Recruiting
View on ClinicalTrials.gov →
Summary
PROFILE-HF is a multicenter, observational, prospective study of the clinical course and outcomes of chronic heart failure (HF) and coronary artery disease (CAD) in patients undergoing coronary artery bypass grafting (CABG). The objective of the study is to develop a method for assessing the risk of adverse cardiovascular events in patients with CAD and HF who have undergone CABG, based on preoperative GDF-15 concentrations. The study will have a 12-month follow-up period; one in-person visit is planned at the end of the follow-up period. If it is not possible to visit a doctor in person, information will be collected through telephone contact with the patient or his relative or person caring for the patient.
Trial Details
NCT Number NCT07480915
Lead Sponsor Tomsk National Research Medical Center of the Russian Academy of Sciences
Conditions Heart Failure, CAD - Coronary Artery Disease, CABG
Enrollment 160 participants
Start Date 2026-03-04
Primary Completion 2027-03 (estimated)
Study Completion 2028-03 (estimated)
Updated on ClinicalTrials.gov 2026-03-18